• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Azosemide Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5752756

Azosemide is a potent NKCC1 inhibitor (IC50s: 0.246epsilonM and 0.197epsilonM for hNKCC1A and NKCC1B). More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Azosemide, Inhibitor
Full Product Name
Azosemide
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
370.84
Solubility
DMSO: 250mg/mL (674.15mM) Need ultrasonic
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C12H11ClN6O2S2
SMILES
ClC1=CC(NCC2=CC=CS2)=C(C3=NN=NN3)C=C1S(N)(=O)=O
CAS Number
27589-33-9
Target & IC50
hNKCC1A: ic50 0.246uM
NKCC1B: ic50 0.197uM
In Vitro
Azosemide shows a shorter terminal half-life (50.9% decrease) and MRT (64.1% decrease), smaller AUC (81.9% decrease), faster CL (454% increase), CLNR (307% increase) and CLR (853% increase) for NARs [2].

Structure of Azosemide, inhibitor

Azosemide Inhibitor – Cat# MBS5752756

Product References and Citations for Azosemide, inhibitor

Hampel P, et al. Azosemide is more potent than bumetanide and various other loop diuretics to inhibit the sodium-potassium-chloride-cotransporter human variants hNKCC1A and hNKCC1B. Sci Rep. 2018 Jun 29;8(1):9877.
Hampel P, et al. Azosemide is more potent than bumetanide and various other loop diuretics to inhibit the sodium-potassium-chloride-cotransporter human variants hNKCC1A and hNKCC1B. Sci Rep. 2018 Jun 29;8(1):9877.
Kim EJ, et al. Pharmacokinetics and pharmacodynamics of intravenous azosemide in mutant Nagaseanalbuminemic rats. Drug Metab Dispos. 2003 Feb;31(2):194-201.
Kim EJ, et al. Pharmacokinetics and pharmacodynamics of intravenous azosemide in mutant Nagaseanalbuminemic rats. Drug Metab Dispos. 2003 Feb;31(2):194-201.

Other Notes

Small volumes of Azosemide, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Azosemide purchase

MBS5752756 is an inhibitor targeting Azosemide.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000